3.98 USD
-0.23 (-5.46%)
4.18 USD
+0.2 (+5.03%)
ChartMill assigns a Buy % Consensus number of 80% to NEUP. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 14.72. This target is 269.9% above the current price.
NEUP was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about NEUP.
In the previous month the buy percentage consensus was at a similar level.
NEUP was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-09-11 | Maxim Group | Maintains | Buy -> Buy |
| 2025-08-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-04 | HC Wainwright & Co. | Maintains | Buy -> Buy |
NEUPHORIA THERAPEUTICS INC / NEUP FAQ
What is the price target for NEUP stock?
9 analysts have analysed NEUP and the average price target is 14.72 USD. This implies a price increase of 269.9% is expected in the next year compared to the current price of 3.98.
Can you provide the consensus rating for NEUPHORIA THERAPEUTICS INC stock?
The consensus rating for NEUPHORIA THERAPEUTICS INC (NEUP) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover NEUPHORIA THERAPEUTICS INC (NEUP) stock?
The number of analysts covering NEUPHORIA THERAPEUTICS INC (NEUP) is 9.